Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Diagnostics (Basel, Switzerland)|November 27, 2021
From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A ReviewThibault Comont, Emmanuel Treiner, François VergezBulletin Du Cancer|September 24, 2018
[Minimal residual disease in chronic lymphocytic leukemia: A still current issue in 2018]Martin Gauthier, Thibault Comont, François Vergez, et al.Journal for Immunotherapy of Cancer|November 18, 2018
Immune checkpoint inhibitor-related acral vasculitisThibault Comont, Vincent Sibaud, Loïc Mourey, et al.Annals of Hematology|January 19, 2026
Immune checkpoint inhibitor-induced pure red cell aplasia: a nationwide retrospective case series and literature reviewSirivanh Bisiou, Hervé Lobbes, Pascale Palassin, et al.Cancer Immunology, Immunotherapy : CII|September 3, 2021
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutationsThibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.La Revue Du Praticien|June 6, 2025
[VEXAS Syndrome]Vincent Jachiet, Thibault Comont, Olivier Kosmider, et al.Rheumatology (Oxford, England)|November 9, 2020
Low dose IL-2 in patients with steroid-dependent dysimmune manifestations associated with myelodysplastic syndromes: a three-case reportMarion Corfmat, Christophe Willekens, Julien Vinit, et al.La Revue De Medecine Interne|May 24, 2025
[Siltuximab as a salvage therapy in multi-refractory adult-onset Still's disease: A case series]Julie Moreau, Amélie Leurs, Emmanuel Ledoult, et al.Expert Review of Hematology|November 22, 2022
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive reviewChristophe Ferreira de Matos, Thibault Comont, Marie-Pierre Castex, et al.Clinical Lymphoma, Myeloma & Leukemia|July 11, 2025
Incidence and Burden of Lower-Risk Myelodysplastic Syndrome: A Nationwide Population StudyMaud D'Aveni, Jérôme Fernandes, Mélanie Chartier, et al.Pageof 5